Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (246)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Pilaralisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Pilaralisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Zandelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Zandelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Linperlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Linperlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Everolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Everolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Temsirolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Temsirolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sirolimus (Oncology Use)	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Sirolimus (Oncology Use) Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Ridaforolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Ridaforolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Vistusertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Vistusertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sapanisertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Sapanisertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Onatasertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Onatasertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Palbociclib	CDK Inhibitor	Solid Tumour
Molecule Palbociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib	CDK Inhibitor	Solid Tumour
Molecule Ribociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

Pilaralisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Zandelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Linperlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Everolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Temsirolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sirolimus (Oncology Use) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Ridaforolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Vistusertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sapanisertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Onatasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Palbociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

‹ 1 … 9 10 11 12 13 … 21 ›

Product Range

Company

Global Network

Products

Pilaralisib

Zandelisib

Linperlisib

Everolimus

Temsirolimus

Sirolimus (Oncology Use)

Ridaforolimus

Vistusertib

Sapanisertib

Onatasertib

Palbociclib

Ribociclib